Teva Pharmaceutical Industries News

Teva Pharmaceutical Industries Ltd was in 47 hedge funds' portfolio at the end of March.

Teva Pharmaceutical Industries Ltd., which just two years ago was analysts' highest-rated stock among the world's 20 biggest drugmakers, is struggling to convince investors that a key part of its strategy will revive growth.

Israel plans to amend a law granting companies tax breaks and grants to invest in the country as the government tries to close a widening budget deficit.

Teva Pharmaceutical is a widely followed Israel-based global pharmaceutical company; however, besides its popular Copaxone drug, I did not find a lot of studies about the other drug candidates in its pipeline.

In April, a Reagan-appointed federal judge issued an order to make the so-called "morning after" pill available over the counter to everyone regardless of their age.

Alexza Pharmaceuticals, Inc. today reported financial results for the fiscal quarter March 31, 2013.

Good afternoon, everyone, and welcome to the Alexza Pharmaceuticals 2013 First Quarter Financial Results Conference Call.

Actavis Inc. rejected a cash-and-stock offer from fellow generic drugmaker Mylan Inc.

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today! Teva Pharmaceutical Industries Ltd.

"Teva Pharmaceutical Industries has been reiterated by TheStreet Ratings as a hold with a ratings score of C+. The company's strengths can be seen in multiple areas, such as its reasonable valuation levels, good cash flow from operations and largely solid financial position with reasonable debt levels by most measures.

The French Competition Authority said on Tuesday it fined drugmaker Sanofi 40.6 million euros over what it called a smear campaign aimed at stifling generic competition to its blood thinner, Plavix.

May 11, 2013 -- Sagent Pharma, a US generic injectible drugmaker, will pay $25 million to acquire its partner's 50% interest in a China manufacturing JV; ScinoPharm Taiwan and Coland Holdings formed a partnership to bring generic oncology drugs to mainland China; Zhejiang Huahai Pharma joined with Oncobiologics to develop and make biosimilars of ... (more)

A study released by the IMS Institute for Health Informatics finds that per capita spending on medicines declined by $33 in 2012.

Endo Health Solutions Inc. lost an effort to stop U.S. sales of generic versions of its extended-release painkiller that don't have tamper-resistant qualities.

's stock had its "hold" rating restated by analysts at TheStreet in a research report issued to clients and investors on Friday, StockRatingsNetwork reports.

Finance Minister Yair Lapid met with Teva CEO Jeremy Levin on Friday to discuss Lapid's intentions to raise taxes for large corporations.

A federal judge rejected as "frivolous" a government request to delay the effect of his order giving girls of all ages access to the so-called morning after-pill. U.S. District Judge Edward R. Korman in Brooklyn, New York, refused today to put the ruling on hold while the government appeals his decision that the contraceptive doesn't require a ... (more)

Finance Minister Yair Lapid met with Teva CEO Jeremy Levin on Friday to discuss Lapid's intentions to raise taxes for large corporations.

Teva Pharmaceutical Industries Limited : Jim Cramer ranked this stock a Sell . Cramer previously ranked this stock a Sell on April 11, 2013.

StockCall.com Provides Stock Research on Mylan Inc., Teva Pharmaceutical Industries Ltd, Covidien plc, Valeant Pharmaceuticals International Inc., and Zoetis Inc.